I tend to agree with this comment (obviously won't cross promote). I think in general the lack of cash versus 'ARR, ACV, CARR, or whatever you want to use' will be looked at more closely. If you think about it more generally, 3DP, should have bargaining power given the lack of direct competitors.
The ARR multiple at current prices is still on the high side for 3DP (versus peers) but it rightfully should be given the consistent growth that's being delivered.
Overall the stock is on the undervalued side despite some of the comments I/others have made.
- Forums
- ASX - By Stock
- 3DP
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-83
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 3DP (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.002(4.76%) |
Mkt cap ! $33.00M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.0¢ | $22.36K | 557.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 314821 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 180494 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 314821 | 0.039 |
5 | 143446 | 0.038 |
2 | 120000 | 0.037 |
3 | 300300 | 0.036 |
2 | 178599 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 180494 | 1 |
0.041 | 1948026 | 2 |
0.042 | 25773 | 2 |
0.043 | 150000 | 1 |
0.044 | 100000 | 1 |
Last trade - 15.23pm 12/11/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online